Company / EPS (Diluted)
CLOVER HEALTH INVESTMENTS, CORP. /DE EPS (Diluted) History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.44
FY2023
5-year range
-$4.14 / -$0.44
FY2019-FY2023
Trend
+71.4%
vs FY2022
Sector context
#117 of 159
Health Care
What the data says
At $-0.44, CLOVER HEALTH INVESTMENTS, CORP. /DE's eps (diluted) ranks #117 of 159 in the Health Care sector. Improved from $-4.14 to $-0.44 over the past 2 years.
Based on SEC 10-K filings.
-0.44 in FY2023.
Improved from $-4.14 to $-0.44 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#117 of 159 in Health CareTop 74% of 159This company -$0.44 Sector average $2.35
▼
-118.7% below sector average
Key checks
Key Insights
- In FY2023, eps (diluted) increased 71.4% year-over-year.
- Ranks #117 out of 159 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | -$0.44 | +71.4% |
| FY2022 | -$1.54 | +62.8% |
| FY2021 | -$4.14 | -168.8% |
| FY2020 | -$1.54 | +62.8% |
| FY2019 | -$4.14 | - |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026